Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 1 45-1, 1999, Pages

  Kumar, Anand ^a   Brar, Rupinder ^a   Wang, Peter ^a   Dee, Linda ^a   Skorupa, Greg ^a   Khadour, Fadi ^b   Schulz, Richard ^b   Parrillo, Joseph E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cyclic nucleotide; Cytokine; Heart contractility; Myocardial depressant factor; Septicemia

Indexed keywords

ARGININE; CYCLIC GMP; GUANYLATE CYCLASE; INTERLEUKIN 1BETA; METHYLENE BLUE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SEPTICEMIA;

EID: 0032891779     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.1.r265     Document Type: Article

References (68)

1. Archer, S. L., K. A. Freude, and P. J. Shultz. Effect of graded hypoxia on the induction and function of inducible nitric oxide synthase in rat mesangial cells. Circ. Res. 77: 21-28, 1995.
2. Balligand, J. L., R. A. Kelly, P. A. Marsden, T. W. Smith, and T. Michel. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90: 347-351, 1993.
3. Balligand, J. L., L. Kobzik, X. Han, D. M. Kaye, L. Belhassen, D. S. O'hara, R. A. Kelly, T. W. Smith, and T. Michel. Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270: 14582-14586, 1995.
4. Balligand, J. L., D. Ungureanu, R. A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T. W. Smith. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314-2319, 1993.
5. Balligand, J. L., D. Ungureanu-Longrois, W. W. Simmons, D. Pimental, T. A. Malinski, M. Kapturczak, Z. Taha, C. J. Lowenstein, A. J. Davidoff, R. A. Kelly, T. W. Smith, and T. Michel. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J. Biol. Chem. 269: 27580-27588, 1994.
6. Bernard, C., B. Szekely, I. Philip, E. Wollman, D. Payen, and A. Tedgui. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. J. Clin. Invest. 89: 851-860, 1992.
7. Bohm, M., R. Kirchmayr, P. Gierschik, and E. Erdmann. Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am. J. Med. 98: 183-186, 1995.
8. Brady, A. J., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1963-H1966, 1992.
9. Brady, A. J., J. B. Warren, P. A. Poole-Wilson, T. J. Williams, and S. E. Harding. Nitric oxide attentuates cardiac myocyte contraction. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H176-H182, 1993.
10. Brien, J. F., B. E. McLaughlin, K. Nakatsu, and G. S. Marks. Chemiluminescence headspace-gas analysis for determination of nitric oxide formation in biological systems. Methods Enzymol. 268: 83-92, 1996.
11. Cain, B. S., D. R. Meldrum, C. A. Dinarello, X. Meng, K. S. Joo, and A. H. A. H. Banerjee. TNF-alpha and IL-1beta synergistically depress human myocardial function. Crit Care Med. In press.
12. Calandra, T., J. Baumgartner, G. E. Grau, M. Wu, P. Lambert, J. Schellekens, J. Verhoef, and M. P. Glauser. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, and interferon-gamma in the serum of patients with septic shock. J. Infect. Dis. 161: 982-987, 1990.
13. Casey, L. C., R. A. Balk, and R. C. Bone. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119: 771-778, 1993.
14. Chung, M. K., T. S. Gulick, R. E. Rotondo, G. F. Schreiner, and L. G. Lange. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myoctyes: impairment of signal transduction. Circ. Res. 67: 753-763, 1990.
15. Cooper, R. H., M. McPherson, and J. G. Schofield. The effect of prostaglandins on ox pituitary content of adenosine 3′: 5′-cyclic monophosphate and the release of growth hormone. Biochem. J. 127: 143-154, 1972.
16. Cunha, F. Q., J. Assreuy, D. W. Moss, D. Rees, L. M. Leal, S. Moncada, M. Carrier, C. A. O'Donnell, and F. Y. Liew. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 81: 211-215, 1994.
17. De Belder, A. J., M. W. Radomski, H. J. F. Why, P. J. Richardson, C. A. Bucknall, E. Salas, J. F. Martin, and S. Moncada. Nitric oxide synthase activities in the human myocardium. Lancet 341: 84-85, 1993.
18. Decking, U. K. M., C. W. Flesche, A. Godecke, and J. Schrader. Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2460-H2465, 1995.
19. DeMeules, J. E., F. A. Pigula, M. Mueller, S. J. Raymond, and R. L. Gamelli. Tumor necrosis factor and cardiac function. J. Trauma 32: 686-692, 1992.
20. Eichenholz, P. W., P. Q. Eichacker, W. D. Hoffman, S. M. Banks, J. E. Parrillo, R. L. Danner, and C. Natanson. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H668-H675, 1992.
21. Evans, H. G., M. J. Lewis, and A. M. Shah. Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc. Res. 27: 1486-1490, 1993.
22. Finkel, M. S., C. V. Oddis, T. D. Jacobs, S. C. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992.
23. Fleming, I., T. Dambacher, and R. Busse. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J. Cardiovasc. Pharmacol. 20, Suppl. 12: S135-S138, 1992.
24. Garcia-Cardena, G., R. Fan, V. Shah, R. Sorrentino, G. Cirino, A. Papapetropoulos, and W. C. Sessa. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
25. Girardin, E., G. E. Grau, J. M. Dayer, P. Roux-Lombard, and P. H. Lambert. Plasma tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319: 397-400, 1989.
26. i and contractility in isolated adult rabbit ventricular myocytes. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1449-H1455, 1996.
27. Gulick, T., M. K. Chung, S. J. Pieper, L. G. Lange, and G. F. Schreiner. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte adrenergic responsiveness. Proc. Natl. Acad. Sci. USA 86: 6753-6757, 1989.
28. 2+ current in adult rabbit atrioventricular nodal cells. Circ. Res. 78: 998-1008, 1996.
29. Harary, I., and B. Farley. In-vitro studies of single isolated beating rat heart cells. Science 131: 1674-1675, 1960.
30. Hare, J. M., J. F. Keaney, J. L. Balligand, J. Loscalzo, T. W. Smith, and W. S. Colucci. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J. Clin. Invest. 95: 360-366, 1995.
31. Hare, J. M., E. Loh, M. A. Creager, and W. S. Colucci. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92: 2198-2203, 1995.
32. Hollenberg, S. M., R. E. Cunnion, and J. Zimmerberg. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H660-H663, 1993.
33. Hosenpud, J. D., S. M. Campbell, and D. J. Mendelson. Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J. Heart Transplant. 8: 460-464, 1989.
34. Jha, P., H. Jacobs, D. Bose, R. Wang, J. Yang, R. B. Light, and S. Mink. Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dog ventricle. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1402-H1410, 1993.
35. Julou-Schaeffer, G., G. A. Gray, I. Fleming, C. Schott, J. R. Parratt, and J. C. Stoclet. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1038-H1043, 1990.
36. Kaye, D. M., S. D. Wiviott, J. L. Balligand, W. W. Simmons, T. W. Smith, and R. A. Kelly. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ. Res. 78: 217-224, 1996.
37. i and cell contraction in cultured chick ventricular myocytes. Circ. Res. 75: 285-295, 1994.
38. Kumar, A., R. Kosuri, B. Ginsburg, L. Dee, J. Kim, J. Olson, E. Uretz, L. C. Casey, and J. E. Parrillo. Myocardial cell contractility is depressed by supernatants of endotoxin stimulated THP-1 cells (Abstract). Crit. Care Med. 22: A118, 1994.
39. Kumar, A., V. Thota, L. Dee, J. Olson, E. Uretz, and J. E. Parrillo. Tumor necrosis factor-alpha and interleukin-1 beta are responsible for depression of in-vitro myocardial cell contractility induced by serum from humans with septic shock. J. Exp. Med. 183: 949-958, 1996.
40. LaPointe, M. C., and J. R. Sitkins. Mechanisms of interleukin-1 beta regulation of nitric oxide synthase in cardiac myocytes. Hypertension 27: 709-714, 1996.
41. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA 88: 1197-1201, 1991.
42. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylate cyclase activation. J. Biol. Chem. 268: 26286-26295, 1994.
43. Oral, H., G. W. Dorn, and D. L. Mann. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J. Biol. Chem. 272: 4836-4841, 1997.
44. Parker, M. M., K. E. McCarthy, F. P. Ognibene, and J. E. Parrillo. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97: 126-131, 1990.
45. Parker, M. M., J. H. Shelhamer, S. L. Bacharach, M. V. Green, C. Natanson, T. M. Frederick, B. A. Damske, and J. E. Parrillo. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100: 483-490, 1984.
46. Parrillo, J. E., C. Burch, J. H. Shelhamer, M. M. Parker, C. Natanson, and W. Schuette. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76: 1539-1553, 1985.
47. Rees, D. D., S. Cellek, R. M. J. Palmer, and S. Moncada. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxic shock. Biochem. Biophys. Res. Commun. 173: 541-547, 1990.
48. Reilly, J. M., R. E. Cunnion, C. Burch-Whitman, M. M. Parker, J. H. Shelhamer, and J. E. Parrillo. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest 95: 1072-1080, 1989.
49. Reithmann, C., S. Hallstrom, G. Pilz, T. Kapsner, G. Schlag, and K. Werdan. Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ. Shock 41: 48-59, 1993.
50. Rozanski, G. J., and R. C. Witt. IL-1 inhibits β-adrenergic control of cardiac calcium current: role of L-arginine/nitric oxide pathway. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1753-H1758, 1994.
51. Salvemini, D., R. Korbut, E. Anggard, and J. R. Vane. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87: 2593-2597, 1990.
52. Schuette, W. H., C. Burch, P. O. Roach, and J. E. Parrillo. Closed loop television tracking of beating heart cells in vitro. Cytometry 8: 101-103, 1987.
53. 2+)-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105: 575-580, 1992.
54. Schulz, R., D. L. Panas, R. Catena, S. Moncada, P. M. Olley, and G. D. Lopaschuk. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumor necrosis factor-alpha. Br. J. Pharmacol. 114: 27-34, 1995.
55. 2+ in intact cardiac myocytes. Circ. Res. 74: 970-978, 1994.
56. Shindo, T., U. Ikeda, F. Ohkawa, M. Takahashi, H. Funayama, M. Nishinaga, Y. Kawahara, M. Yokoyama, T. Kasahara, and K. Shimada. Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. Life Sci. 55: 1101-1108, 1994.
57. Smith, J. A., M. W. Radomski, R. Schulz, S. Moncada, and M. J. Lewis. Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase. Br. J. Pharmacol. 108: 1107-1110, 1993.
58. Sobotka, P. A., J. McMannis, R. I. Fisher, D. G. Stein, and J. X. Thomas. Effects of interleukin-2 on cardiac function in the isolated rat heart. J. Clin. Invest. 86: 845-850, 1990.
59. Szabo, C., J. A. Mitchell, C. Thiemermann, and J. R. Vane. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108: 786-792, 1993.
60. G-nitro-L-arginine on shock induced by endotoxin and by platelet activating factor in dogs. Eur. J. Pharmacol. 250: 465-467, 1993.
61. Tohse, N., and N. Sperelakis. cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ. Res. 69: 352-331, 1991.
62. Tsujino, M., Y. Hirata, T. Imai, K. Kanno, S. Eguchi, H. Ito, and F. Marumo. Induction of nitric oxide synthetase gene by interleukin-1 beta in cultured rat cardiocytes. Circulation 90: 375-383, 1994.
63. Ungureanu-Longrois, D., J. L. Balligand, I. Okada, W. W. Simmons, L. Kobzik, C. J. Lowenstein, S. L. Kunkel, T. Michel, R. A. Kelly, and T. W. Smith. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ. Res. 77: 486-493, 1995.
64. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169: 333-338, 1989.
65. Wahler, G. M., and S. J. Dollinger. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol. 268 (Cell Physiol. 37): C45-C54, 1995.
66. Walley, K. R., P. C. Hebert, Y. Wakai, P. G. Wilcox, J. D. Road, and D. J. Cooper. Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. J. Appl. Physiol. 76: 1060-1067, 1994.
67. Weyrich, A. S., X. L. Ma, M. Buerke, T. Murohara, V. E. Armstead, A. M. Lefer, J. M. Nicolas, A. P. Thomas, D. J. Lefer, and J. Vinten-Johansen. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ. Res. 75: 692-700, 1994.
68. Yokoyama, T., L. Vaca, R. D. Rossen, W. Durante, P. Hazarika, and D. L. Mann. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J. Clin. Invest. 92: 2303-2312, 1993.